Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Cocrystal Pharma, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 26 | 27 | +1 |
| Shares | 776.2K | 1.11M | +335.9K (+43.3%) |
| Value | $783.8K | $1.17M | +$383.6K (+48.9%) |
New holders (7)
Institutions that held Cocrystal Pharma, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 175,379 | $184.1K | 0.00% |
| Citadel Advisors LLC | 45,118 | $47.4K | 0.00% |
| HRT Financial LP | 20,336 | $21.0K | 0.00% |
| Ground Swell Capital, LLC | 10,752 | $11.3K | 0.01% |
| Barclays PLC | 42 | $44 | 0.00% |
| Allied Private Wealth LLC | 32 | $31 | 0.00% |
| Vima LLC | 17 | $18 | 0.00% |
Sold out (6)
Institutions that held Cocrystal Pharma, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| T3 Companies, LLC | 51,500 | $52.0K |
| Two Sigma Securities, LLC | 15,255 | $15.4K |
| Virtu Financial LLC | 13,080 | $13.0K |
| FMR LLC | 334 | $337 |
| MAI Capital Management | 237 | $240 |
| Citigroup Inc | 1 | $1 |